Latest stories on TNXP
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
Business Insider50 · neutralgeneral
Tonix Pharma announces upcoming retirement of chief medical officer
TipRanks42 · neutralgeneral
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix Pharmaceuticals Expands TONMYA Coverage to 145 Million Lives with Major Medicare Agreement
July 13, 2026
MarketChameleon73 · bullishproduct/pr
Tonix Pharma expands Medicare coverage for TONMYA therapy
TipRanks63 · neutralproduct/pr
Tonix rises on Medicare payer deal for fibromyalgia drug
Seeking Alpha67 · bullishproduct/pr
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix: 'Hold' Based On Tonmya Payer Expansions And MDD Trial Initiation
Seeking Alpha42 · neutralanalyst
Tonix: Slow Start For Tonmya, Speculative Pipeline Warrants Hold Rating
Seeking Alpha48 · neutralproduct/pr
Tonix Pharma Begins Pivotal Phase 2 Depression Trial
TipRanks63 · neutralproduct/pr
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix, MapLight are new Strong Buys at Raymond James on upcoming catalysts
Seeking Alpha67 · bullishanalyst
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 | TNXP Stock News
StockTitan56 · neutralproduct/pr
Why Is TNXP Stock Rising Today?
Stocktwits News63 · neutralproduct/pr
Tonix Pharmaceuticals Expands TONMYA Coverage to 52 Million Commercial Lives: What This Means for Fibromyalgia Patients
MarketChameleon67 · bullishproduct/pr
Tonix Pharma Expands Coverage and Access for TONMYA
TipRanks63 · neutralproduct/pr
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix Advances TNX-102 SL Into Phase 2 Depression Trial, Drawing Investor Focus
TipRanks63 · neutralproduct/pr
Tonix Pharma Highlights Positive Phase 1 TNX-1500 Results
TipRanks63 · neutralproduct/pr